Abstract
Morbidity and mortality among HIV-1-infected individuals has been dramatically reduced by the implementation of combinational antiretroviral therapy (ART). However, the efficiency of these therapies is compromised due to HIV-1 transmitted drug resistance mutations (TDRMs). We collected a total of 127 samples from ART-naïve HIV-infected individuals and sequenced the pol gene and analysed for drug resistance mutations using the Calibrated Population Resistance (CPR) tool in the Stanford database. All the 127 clinical samples (100%) were identified as HIV-1 subtype C. Based on the CPR tool, three strains (2.4%) had TDRMs, and these were K101E, Y181C and G190A. Our findings correlated well with the WHO surveys conducted in Asia, including India, which consistently reported<5% TDRM among the specific populations assessed. In countries like India, regular monitoring of TDRMs will provide better information for clinical practice improvement and policy making.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have